Assert-IQ vs Withings Scan Monitor
AI Verdict
Choose Assert-IQ if…
Choose Assert-IQ if you require a highly reliable, long-term insertable cardiac monitor for continuous and comprehensive arrhythmia detection over several years. This system is best suited for patients with suspected heart rhythm disorders where infrequent or subtle events necessitate prolonged, physician-managed diagnostic monitoring to establish a definitive diagnosis.
View Assert-IQ →Choose Withings Scan Monitor if…
Choose Withings Scan Monitor if you are looking for a convenient, non-invasive solution for regular home-based cardiac health screening and general wellness monitoring. This tool is ideal for individuals or remote patient monitoring programs focused on proactive health management, including FDA-cleared AFib detection via smart scales or smartwatches.
View Withings Scan Monitor →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Assert-IQ | Withings Scan Monitor |
|---|---|---|
| Pricing | Unknown | Device purchase with optional subscription for enhanced features and clinical services. |
| Deployment | Subcutaneously implanted device with mobile app connectivity | Device-based (smart scale, smartwatch) with cloud synchronization and mobile application. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Withings Scan MonitorWithings Scan Monitor integrates into everyday smart scales and smartwatches, offering a seamless and user-friendly experience for patients through its mobile application and automatic data synchronization. Assert-IQ, while minimally invasive, requires a medical procedure for insertion, making its initial adoption less straightforward for the end-user.
Clinical Value
Assert-IQAssert-IQ provides long-term, continuous cardiac monitoring for up to six years, offering advanced arrhythmia detection algorithms crucial for comprehensive diagnosis and management of various heart rhythm disorders. Withings Scan Monitor primarily offers spot-check ECGs for AFib detection and a broader range of general health metrics, which is less comprehensive for continuous cardiac arrhythmia monitoring.
Pricing & Value
Withings Scan MonitorWithings Scan Monitor offers transparent, consumer-friendly pricing with a clear device purchase cost and an optional monthly subscription for enhanced features. Assert-IQ's enterprise pricing is opaque, requiring direct contact with Abbott Medical, making it difficult for a general comparison of value without specific institutional quotes.
Enterprise Readiness
Assert-IQAssert-IQ is explicitly designed for and targets large health systems, hospitals, and cardiology clinics, offering hybrid deployment, HIPAA compliance, FDA clearance, and data export capabilities. While Withings Scan Monitor is HIPAA compliant and FDA cleared for professional remote patient monitoring, its deployment model is primarily device-based with cloud synchronization, and its enterprise integration capabilities are not as extensively detailed for large-scale health system adoption.
Innovation
Withings Scan MonitorWithings Scan Monitor innovates by integrating medical-grade ECG for AFib detection, vascular age assessment, and nerve health scores into accessible consumer smart scales and smartwatches. This multi-modal approach to health monitoring within everyday devices represents a significant advancement in democratizing advanced health insights.
Support & Docs
Assert-IQAbbott Medical, as a major medical device company, provides extensive clinical and technical documentation, including detailed user manuals for its complex ICM system and patient care networks. They offer dedicated technical support lines for healthcare professionals, which is crucial for the intricate nature of an implantable cardiac monitor in an enterprise setting.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Assert-IQ | Withings Scan Monitor |
|---|---|---|
| Product Name | Assert-IQ | Withings Scan Monitor |
| Company | Abbott Medical | Withings |
| Primary Use Case | Long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders. | AI-powered tool offering FDA-cleared ECG for AFib detection, heart rate, and other vital health metrics for both personal use and professional remote patient monitoring. |
| Core Cardiac Monitoring | Long-term continuous cardiac monitoring (up to 6 years), Advanced arrhythmia detection algorithms, Remote monitoring capabilities. | 6-lead ECG for Atrial Fibrillation (AFib) detection (Body Scan), Single-lead ECG for Atrial Fibrillation (AFib) detection (ScanWatch), Heart rate measurement and irregular rhythm notifications. |
| Additional Health Metrics/Features | Proactive clinician alerts, Patient activator for symptom logging. | Blood oxygen saturation (SpO2) measurement (ScanWatch), Vascular Age assessment (Body Scan), Nerve Health Score (Electrodermal Activity) (Body Scan), Segmental body composition analysis (Body Scan). |
| Target User/Setting | Large health systems, hospitals, cardiology clinics | Personal use and professional remote patient monitoring. |
Videos
Demos, reviews, and walkthroughs featuring Assert-IQ and Withings Scan Monitor.